About Ocimum Biosolutions
Ocimum Biosolutions is a company based in Hyderabad (India) founded in 2000 by Linga Reddy Venkata Subba Reddy. It operates as a Professional Services and SaaS (Software-as-a-Service). Ocimum Biosolutions has raised $41.99 million across 4 funding rounds from investors including International Finance Corporation, Kubera Cross-Border Fund and Kubera Partners. The company has 24 employees as of April 02, 2024. Ocimum Biosolutions offers products and services including Biotracker™, Sciantis™, and BioExpress® System. Ocimum Biosolutions operates in a competitive market with competitors including BGI, Genewiz, CosmosID, Acclinate and Macrogen, among others.
- Headquarter Hyderabad, India
- Employees 24 as on 02 Apr, 2024
- Founders Linga Reddy Venkata Subba Reddy
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ocimum Biosolutions Ltd.
- Date of Incorporation 12 Mar, 2001
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$71.99 K (USD)-91.35as on Mar 31, 2022
-
Net Profit
-$112.3 K (USD)31.64as on Mar 31, 2022
-
EBITDA
$64.18 K (USD)16.75as on Mar 31, 2022
-
Total Equity Funding
$41.99 M (USD)
in 4 rounds
-
Latest Funding Round
$17 M (USD), Series D
Jun 14, 2013
-
Investors
International Finance Corporation
& 2 more
-
Employee Count
24
as on Apr 02, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ocimum Biosolutions
Ocimum Biosolutions offers a comprehensive portfolio of products and services, including Biotracker™, Sciantis™, and BioExpress® System.
Laboratory data and sample management is facilitated by Biotracker™.
Biologics process tracking and analytics are supported by Sciantis™.
Gene expression reference data is provided by BioExpress® System.
Funding Insights of Ocimum Biosolutions
Ocimum Biosolutions has successfully raised a total of $41.99M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $17 million completed in June 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Ocimum Biosolutions
Ocimum Biosolutions has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include International Finance Corporation, Kubera Cross-Border Fund and Kubera Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are directed toward US and India markets.
|
Locked | Locked | Locked | |
|
IFC is focused on private sector development in emerging markets.
|
Locked | Locked | Locked | |
|
PE firm investing in North America,Europe & Asia
|
Locked | Locked | Locked |
Investor details for Ocimum Biosolutions
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ocimum Biosolutions
Investment portfolio details for Ocimum Biosolutions
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ocimum Biosolutions
Detailed financials for Ocimum Biosolutions
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ocimum Biosolutions Comparisons
Peer comparison for Ocimum Biosolutions
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ocimum Biosolutions
Ocimum Biosolutions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BGI, Genewiz, CosmosID, Acclinate and Macrogen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
BGI is engaged in genomics and precision medicine solutions.
|
|
| Locked | Locked | Locked |
Genomic services are provided for the life sciences industry.
|
|
| Locked | Locked | Locked |
Next-generation sequencing technologies for microorganism detection are developed.
|
|
| Locked | Locked | Locked |
Clinical trial services are provided to the biopharma sector.
|
|
| Locked | Locked | Locked |
Next-generation sequencing and genomics services are provided globally.
|
|
| Locked | Locked | Locked |
Automated genotyping services for murine cell lines are developed.
|
Detailed competitors of Ocimum Biosolutions
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ocimum Biosolutions
Complete news archive for Ocimum Biosolutions
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ocimum Biosolutions
Ocimum Biosolutions was founded in 2000 and raised its 1st funding round 6 years after it was founded.
Ocimum Biosolutions is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Anand Sagar is the current CEO of Ocimum Biosolutions.
Ocimum Biosolutions is a funded company, having raised a total of $41.99M across 4 funding rounds to date.
As of Apr 02, 2024, the latest employee count at Ocimum Biosolutions is 24.
Annual revenue of Ocimum Biosolutions is $71.99K as on Mar 31, 2022.
Comprehensive life science informatics solutions are offered by Ocimum Biosolutions. Services include sample and data management through LIMS and biologics data systems. Genomics data analysis, such as gene expression and next-gen sequencing, is supported. Bioinformatics tools and databases like BioExpress and ToxExpress are maintained. The company serves industries including bioagri, biobanking, core facilities, and hospitals. Consulting in bio-IT and lab services for clinical trials are also provided. Focus is placed on delivering efficient management and analytical tools for scientific research.
Ocimum Biosolutions offers Biotracker™, Sciantis™, and BioExpress® System.
Ocimum Biosolutions has 3 investors. Key investors include International Finance Corporation, Kubera Cross-Border Fund, and Kubera Partners.
The valuation of Ocimum Biosolutions is $74.06M as of Dec 2007.